New Retina Radio Journal Club w/ VBS: Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab

06.22.26

Spotlight on UNITY® VCS: Experience Extraordinary

Kourous Rezaei, MD; with Lejla Vajzovic, MD, FASRS and Aleksandra Rachitskaya, MD, FASRS

06.18.26

ARVO '26: TKIs for Wet AMD and How We Got to the AI Era of Research

Akshay Thomas, MD; Aaron Lee, MD, MSCI; and Cecelia Lee, MD, MS

06.15.26

Spotlight on UNITY^® VCS Dynamic Stiffener 27+

Christina Weng, MD, MBA, FASRS; Mrinali Gupta, MD, FASRS; and Omesh Gupta, MD, MBA

06.08.26

Spotlight on UNITY® VCS: UNITY for All

Sarwar Zahid, MD, FASRS; John Kitchens, MD and Matthew Cunningham, MD, FASRS

06.04.26

ARVO '26: DME Delphi Study and RHONE-X

Baruch Kuppermann, MD, PhD; and Murtaza Adam, MD

05.15.26

New Retina Radio Journal Club w/ VBS: Observation vs. Vitrectomy for Floaters

Kyle Kovacs, MD; Matthew Starr, MD; and Nita Valikodath, MD

05.11.26

The Fellow Eye: Episode 4

David Fell, MD; Justin C. Muste, MD; Allen C. Ho, MD; and Curtis Heisel, MD, MBA

05.08.26

Extending Treatment Efficacy in Wet AMD

Lejla Vajzovic, MD; Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi

05.04.26

The Retina Roundup from Medical to Surgical

Katharine Talcott, MD, and Jorge Fortun, MD

04.15.26

Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR

Jordan Deaner, MD; Vaidehi Dedania, MD; and Rehan Hussain, MD

03.19.26

GLP-1 Use and AMD Risk

Barton Blackorby, MD, Katharine Talcott, MD, and Hong-Uyen Hua, MD

03.16.26

Spotlight on UNITY^® VCS: Intelligent Fluidics

Jay Sridhar, MD; Steve Charles, MD, FACS, FICS, FASRS; and Maria Berrocal, MD

03.05.26

The Fellow Eye: Episode 3

David Fell, MD; Justin C. Muste, MD; Danny Mammo, MD; and Sean Berkowitz, MD

02.24.26

Mentoring in Retina: Addressing Economic Diversity

Katherine E. Talcott, MD; Yoshihiro Yonekawa, MD; and Adrienne W. Scott, MD

02.19.26

New Retina Radio Journal Club w/ VBS: Outcomes for PDR Patients LTFU for at Least 1 Year

Kyle Kovacs, MD; Matt Starr, MD; and Nita Valikodath, MD, MS

02.12.26

The Fellow Eye: Episode 2

David Fell, MD; Justin Muste, MD; Joshua H. Uhr, MD; and Arnulfo Garza-Reyes, MD

02.05.26

What I Wish I Knew: Insights From the Next Generation of Retina Specialists

Nemo Patel, MD; Sam Minaker, MD; and Has Al-khersan, MD

02.05.26

Practical Insights on Adopting FDA-Approved Treatments Into Practice

Nemo Patel, MD; Danny Mammo, MD; and Matthew Donovan, MD

02.05.26

The Race to Slow GA: A Retina Specialist in the Driver’s Seat of GA Treatment

Nemo Patel, MD and Patrick Staropoli, MD

01.15.26

New Retina Radio Journal Club w/ VBS: Diagnosis Delays in Stargardt Disease

Alexis Warren, MD; Jesse Sengillo, MD; and Sruthi Arepalli, MD

01.08.26

The Fellow Eye: Episode 1

David Fell MD; Justin Muste, MD; Flavius Beca, MD

12.18.25

New Retina Radio Journal Club w/ VBS: Assessing Surgical Competency Among Retina Fellows: Perspectives from Directors and Graduates

Nikisha Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD

12.09.25

DME, DR, and Next-Generation Therapies

David Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD

12.09.25

Wet AMD and Next-Generation Therapies

David Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD

12.04.25

Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 3 of 3)

Jay Sridhar, MD; Durga Borkar, MD, MMCi; and Christina Weng, MD, MBA

12.04.25

Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 2 of 3)

Jay Sridhar, MD; Maggie Runner, MD; and Veeral Sheth, MD, MBA

12.04.25

Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 1 of 3)

Jay Sridhar, MD; Danny Mammo, MD; and David Sarraf, MD

11.25.25

Global Discussions in GA: Educating Patients and Encouraging Follow-Up

Anat Loewenstein, MD; Jordi Monés, MD, PhD; Sobha Sivaprasad, MD; and Giovanni Staurenghi, MD

11.25.25

Global Discussions in GA: Referral Patterns and Fellow-Eye Monitoring

Anat Loewenstein, MD; Jordi Monés, MD, PhD; Sobha Sivaprasad, MD; and Giovanni Staurenghi, MD

11.21.25

Endophthalmitis Rates With and Without Antibiotic Prophylaxis

Sruthi Arepalli, MD; Jesse Sengillo, MD; and Alexis Warren, MD

11.17.25

The Nuts and Bolts of GA Therapy: Wrapping Up the Conversation

Charles Wykoff, MD, PhD; Sruthi Arepalli, MD; and Kenneth Fan, MD, MBA

11.13.25

AAO '25: GLP-1s and AMD, and Parity in Retina Care

Aleksandra Rachitskaya, MD; and Julia Haller, MD

11.10.25

Late-Breaking Talks at AAO '25: Phase 3 for Uveitic Macular Edema and GATHER2 OLE

Rahul Khurana, MD; and Arshad Khanani, MD, MA

11.06.25

AAO '25: Dry AMD Pipeline and Oral Treatment for Stargardt Disease

Peter Kaiser, MD; and Michel Michaelides, MD

11.03.25

The Nuts and Bolts of GA Therapy: The Discussions Continue

Charles Wykoff, MD, PhD; Hasenin Al-khersan, MD; and Nakul Singh, MD

10.23.25

Late-Breaking Talks at AAO '25: Gene Therapy for RP and NPDR

Allen Ho, MD; and Charles Wykoff, MD, PhD

10.10.25

New Retina Radio Journal Club w/ VBS: Time-Driven Cost Analysis of PRP: Dollars, Minutes, and Patient Care

Niki Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD

10.09.25

The Nuts and Bolts of GA Therapy: The Opening Sessions

Charles Wykoff, MD, PhD; with Maryam Ghiassi, MD, MHS, and Matthew Cunningham, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring Vision

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Patient Education and Setting Expectations

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Social Impact and Early Intervention

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

09.26.25

New Retina Radio Journal Club w/ VBS: Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab

Ben Young, MD; Pheobe Mellen, MD; and Jordan Deaner, MD

09.04.25

ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDR

David Lally, MD; and Ehsan Rahimy, MD

08.21.25

ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human Graders

John Kitchens, MD; Krishna Mukkamala, MD

08.13.25

New Retina Radio Journal Club w/ VBS: Obstructive Sleep Apnea and Diabetic Retinopathy

Lediana Goduni, MD, Alexis Warren, MD, and Joshua Uhr, MD

07.21.25

The State of Geographic Atrophy Around the Globe: Part 2 of 2

Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD

07.21.25

The State of Geographic Atrophy Around the Globe: Part 1 of 2

Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD

07.18.25

Diabetic Retinopathy Severity and Income Status

Ben Young, MD; Phoebe Mellen, MD; and Jordan Deaner, MD

07.07.25

GA in 2025: Conversion to Wet AMD and Educating Patients on the Value of Continuing Therapy

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

07.07.25

GA in 2025: Dosing Regimens, Drug Selection, and Ideal Candidates

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

06.20.25

Photobiomodulation for Age-related Macular Degeneration

Moderator Barton Blackorby, MD; Hong-Uyen Hua, MD; and Louis Cai, MD

06.12.25

Duke AVS Clips: PVR, DR, Imaging, and MTM

Jason Hsu, MD; Majda Hadziahmetovic, MD; Aleksandra Rachitskaya, MD; Gavin Tan, MD, PhD, FRCSed

06.09.25

Duke AVS Clips: Pediatrics, Anesthesia Trends, and AI

Lejla Vajzovic, MD; Jason Fan, MD; Glen J. Jaffe, MD

06.05.25

Duke AVS Clips: Gene Therapy, RDs, IOLs, and PVDs

Avni P. Finn, MD, MBA; Lejla Vajzovic, MD, MBA; David Zacks, MD, PhD; Dilraj S. Grewal, MD; Xi Chen, MD, PhD; Yuxi Zheng, MD; Durga Borkar, MD; and Yannek I. Leiderman, MD, PhD

05.29.25

ARVO '25: ISTH0036 in Wet AMD/DME, and New Photobiomodulation Data

Marion Munk, MD, PhD; and Diana Do, MD

05.22.25

ARVO '25: Real-World Next-Gen Anti-VEGF Dosing and TKIs in the Pipeline

David Miller, MD; and Robert Wang, MD

05.16.25

GLP-1s and Risk of Age-Related Ocular Disease

05.07.25

Fellow Eye RRD Risk per IRIS Registry

Barton Blackorby, MD; Louis Cai, MD; and Hong-Uyen Hua, MD

03.21.25

Rates of Ocular AEs After Faricimab Injection

Maura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD

01.09.25

OCT Angiography in a Real-world CSR Case

Yasha Modi, MD, and Kat Talcott, MD

01.09.25

Using OCT Angiography to Distinguish RVO and RAO

Yasha Modi, MD, and Kat Talcott, MD,

12.19.24

Switching from Aflibercept to Faricimab in Wet AMD Patients

Ben Young, MD, MS; Lediana Goduni, MD; and Joshua Uhr, MD,

12.12.24

GA Options in Clinical Therapy: Which Patients Are a Fit for GA Treatment?

John Kitchens, MD; Saradha Chexal, MD; and Geeta Lalwani, MD

12.05.24

AAO '24: Real-world PDR Treatment vs. Protocol S Guidelines, and Retinal Imaging for Alzheimer's

Adrienne Scott, MD; and Dilraj Grewal, MD

11.21.24

New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk?

Moderator Rebecca Soares, MD; Matt Starr, MD; and Nikisha Kothari, MD

11.14.24

AAO '24 Late-Breakers: Preventing Fas Activation Prior to RRD Repair, and Phase 2/3 Data on an Oral Therapy for GA

Durga S. Borkar, MD, MMCi; and Alex Melamud, MD

11.07.24

AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

Jeremiah Brown, MD, MS; and Eric Schneider, MD

10.31.24

AAO '24: COVID and Retinal Disease, Plus the Latest on Step Therapy and Declining Reimbursement

Rahul Khurana, MD; and Paul Hahn, MD, PhD

10.28.24

GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

John Kitchens, MD, Miguel Busquets, MD, and Esther Kim, MD

10.17.24

New Retina Radio Journal Club with VBS: Pre-treatment with Chlorhexidine vs. Povidone-Iodine in Endophthalmitis Prevention

Maura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD

10.09.24

Real-World Studies Reported in Lisbon: Untreated GA Progression and High-Dose Aflibercept in Wet AMD, DME, and DR

Ted Leng, MD; and Michael Klufas, MD

09.17.24

New Retina Radio Journal Club w/ VBS: Risk of Death, Stroke, and MI After RAO

Katherine Talcott, MD; Kyle Kovacs, MD; and Phoebe Mellen, MD

09.05.24

ASRS ’24: C1q Inhibition and Metformin for AMD

Joel Pearlman, MD, PhD; and Dimitra Skondra, MD

08.29.24

New Retina Radio Journal Club with VBS: Switching to Faricimab in Wet AMD Patients With a History of Anti-VEGF Therapy

Ben Young, MD, MS; Lediana Goduni, MD; and Josh Uhr, MD,

08.22.24

ASRS ’24: PAVILION at 100 Weeks

Margaret Chang, MD

08.08.24

ASRS ’24: ACP in Patients with Major EZ Attenuation, and GALE Microperimetry Findings

Katherine Talcott, MD; and Sunir Garg, MD

07.19.24

New Retina Radio Journal Club w/ VBS: Risk Factors for Switching from Bevacizumab to Aflibercept in Protocol AC

Rebecca Soares, MD; Matt Starr, MD; and Nikisha Kothari, MD

07.11.24

From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME

John Kitchens, MD and Maria Berrocal, MD

06.27.24

New Retina Radio Journal Club w/ VBS: RVOs During the COVID Pandemic

Katherine Talcott, MD; Phoebe Mellen, MD and Kyle Kovacs, MD

06.20.24

A Treatment With a Novel MOA for Patients With nAMD and DME: Perspectives From the Real World

John Kitchens, MD; Margaret Chang, MD, MS; and David S. Chin Yee, MD

06.17.24

AMD and DME Applications in the Retina Practice: Real-world Data

Paul Hahn, MD, PhD; Durga Borkar, MD, MMCi; and Ted Leng, MD

06.05.24

ARVO 2024 Coverage: UWF Leakage in Protocol AA, Machine Learning, and GA's Link to Anxiety/Depression

Justis Ehlers, MD; and Lisa Faia, MD

05.29.24

New Retina Radio Journal Club with VBS: Is Buckling Effective for RRD in Patients at Risk for PVR?

David Xu, MD; Barton Blackorby, MD; and Prethy Rao, MD, MPH

05.17.24

ARVO 2024 Coverage: ≥20-week Dosing in PULSAR and TENAYA/LUCERNE

Philip Storey, MD; and Prof. Sobha Sivaprasad

05.10.24

GA Options in Clinical Therapy, Part 2: Real-World Cases in GA

David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD

05.10.24

GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment Strategies

David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD

05.08.24

AMD and DME Applications in the Retina Practice: RCT Comparison

Paul Hahn, MD, PhD; Durga Borkar, MD, MMCi; and Ted Leng, MD

04.25.24

The State of Biosimilars: Integration of Biosimilars into a Retina Practice

John W. Kitchens, MD (Moderator); David Brown, MD; and Kristin Yockus

04.19.24

New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

Sruthi Arepalli, MD; Vaidehi Dedania, MD; and Rebecca Soares, MD, MPH

04.02.24

Successful Management of Vitreous Opacities

John Kitchens, MD, Edwin H. Ryan, MD, Christina Y. Weng, MD, MBA, and Alison Bozung, OD

03.28.24

New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery

Lediana Goduni, MD, Matt Starr, MD, and Joshua Uhr, MD

03.01.24

Treating Geographic Atrophy (GA) In Your Practice

Esther Kim, MD; John W. Kitchens, MD; and Scott Walter, MD

03.01.24

Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy

Esther Kim, MD; John W. Kitchens, MD; and Scott Walter, MD

02.22.24

The State of Biosimilars: How We Got Here and What It Means for Practice

John Kitchens, MD; Carl Awh, MD; Firas Rahhal, MD

02.16.24

Cherchez la Femme Revisited

An interview with Julia A. Haller, MD. By Adrienne W. Scott, MD, and Steven Sanislo, MD

12.14.23

AAO ’23: Downward Trends in Reimbursement and ChatGPT in the Retina Clinic

John Thompson, MD and Raymond Iezzi, MD

12.07.23

New Retina Radio Journal Club: Intentional Suspension of Therapy in Wet AMD

Sruthi Arepalli, MD, Rebecca Soares, MD, MPH, and Vaidehi Dedania, MD

11.30.23

AAO ’23: Real-World Faricimab Patterns and Improving GA Assessments

Sophie Bakri, MD; and Karl Csaky, MD, PhD

11.22.23

New Retina Radio AAO Late-Breakers: PULSAR at 96 Weeks and Home OCT in Wet AMD

Jean-François Korobelnik, MD, PhD; and W. Lloyd Clark, MD

11.21.23

New Retina Radio Journal Club: Prophylactic Laser for Lattice Degeneration in Fellow Eyes After RRD Repair

11.13.23

New Retina Radio AAO Late-Breakers: ALTITUDE and DIAMOND

Mark Barakat, MD; and And Hani Salehi-Had, MD

10.26.23

New Retina Radio Journal Club: Are Postpartum Retinal Detachment Rates Linked to Method of Delivery?

Lediana Goduni, MD, Matt Starr, MD, and Joshua Uhr, MD

10.05.23

Chronic Postoperative Inflammation: Patient Scenarios

John Kitchens, MD; Brian Do, MD; and Katherine Talcott, MD

09.28.23

New Retina Radio Journal Club: Cost Evaluation in DME Therapy

Priya Vakharia, MD, Sruthi Arepalli, MD, and Vaidehi Dedania, MD

09.28.23

New Retina Radio Journal Club: Cost Evaluation in DME Therapy

Priya Vakharia, MD, Sruthi Arepalli, MD, and Vaidehi Dedania, MD

09.25.23

How Imaging Helps Clinics Integrate New Therapies in GA

Aleksandra Rachitskaya, MD; Mrinali Gupta, MD; and Katherine Talcott, MD

09.22.23

Luminaries in Retina: Kirk Packo, MD, FACS (Part 1)

John Kitchens, MD; and Kirk Packo, MD, FACS

09.22.23

Luminaries in Retina: Kirk Packo, MD, FACS (Part 2)

John Kitchens, MD; and Kirk Packo, MD, FACS

09.21.23

Chronic Postoperative Inflammation: Steroids’ Role in Treatment

John Kitchens, MD; Vaidehi Dedania, MD; and David Eichenbaum, MD

09.07.23

New Retina Radio Journal Club: Meta-analysis of PPV for Diabetic TRD

Katherine Talcott, MD, Kyle Kovacs, MD, and Rebecca Soares, MD, MPH

09.01.23

ASRS ’23: Pegcetacoplan Extension Study, and Comparison of Pegcetacoplan and Avacincaptad Pegol

Nathan C. Steinle, MD; and Paul Hahn, MD, PhD

08.25.23

Chronic Postoperative Inflammation: Initial Encounters

John Kitchens, MD; Lisa Faia, MD; and Daniel Kiernan, MD

08.22.23

Imaging Geographic Atrophy: OCT, FAF, NIR, and OCTA

Rishi P. Singh, MD; Roger A. Goldberg, MD, MBA; Mrinali Gupta, MD; Katherine Talcott, MD

08.11.23

ASRS ’23: Missed Injections for AMD/DME/RVO and Anatomic Response to Vabysmo in Wet AMD

Christina Y. Weng, MD, MBA; and Nikolas JS London, MD

07.20.23

New Retina Radio Journal Club: Is Software on Home OCT as Good as Human Graders?

Sabin Dang, MD, Lediana Goduni, MD, and Prethy Rao, MD, MPH

05.25.23

New Retina Radio Journal Club: Wet AMD: Fluid-free Visits' Association with Anatomic and Visual Outcomes

Katherine Talcott, MD; Kyle Kovacs, MD; and Rebecca Soares, MD, MPH

05.18.23

New Retina Radio ARVO Coverage: DME Update: 8-mg Aflibercept data and Faricimab TAE in Phase 3

Diana Do, MD; and Jennifer Lim, MD

05.11.23

New Retina Radio ARVO Coverage: Faricimab in Wet AMD: Real-world and Phase 3 Data

Durga Borkar, MD, MMCi and Varun Chaudhary, MD

05.03.23

Treating GA In Your Clinic

Allen C. Ho, MD; Robert L. Avery, MD; Eleonora M. Lad, MD, PhD; Jeffrey S. Heier, MD; and Dilsher Dhoot, MD

04.20.23

New Retina Radio Journal Club: AMD and Depression Risk

Sabin Dang, MD; Lediana Goduni, MD; and Prethy Rao, MD, MPH

03.28.23

New Retina Radio Journal Club: Duration of Macular Detachment and Final Visual Prognosis

Priya Vakharia, MD; Sruthi Arepalli, MD; and Vaidehi Dedania, MD

03.27.23

The Utility of OCTA in the Clinic

02.23.23

The Era of Geographic Atrophy Treatment Begins

Allen C. Ho, MD; and Robert L. Avery, MD

02.13.23

Inclusion Pearls and Pitfalls For Retina Specialists

Vivienne S. Hau, MD, PhD; Basil K. Williams Jr, MD; Jessica Weinstein, MD; Roberto Diaz-Rohena, MD; Steven Sanislo, MD; and Brandon Johnson, MD

12.29.22

Tips for Mastering Secondary IOLs

Christina Y. Weng, MD, MBA; Ashkan M. Abbey, MD; María H. Berrocal, MD; and Omesh P. Gupta, MD, MBA

12.15.22

New Retina Radio Journal Club: Profiling Punctate Inner Choroidopathy-like Reactions

Yasha Modi, MD; Kyle Kovacs, MD; and Priya Vakharia, MD

12.09.22

George Williams, MD, and Caroline Baumal, MD

12.05.22

Innovations in Retinal Imaging

John Kitchens, MD; Aleksandra Rachitskaya, MD; and Jonathan Russell, MD, PhD

12.01.22

AAO '22 Late-Breaking Talks: Gene Therapies for GA and XLRP

Michel Michaelides, BSc, MB, BS MD(Res), FRCOphth; and Jeffrey Heier, MD

11.17.22

New Retina Radio Journal Club: Biosimilars in Retina: A Pair of Phase 3 Papers

Yasha Modi, MD; Kyle Kovacs, MD; and Priya Vakharia, MD

11.10.22

AAO '22: Biomarkers and AI in the OR

Joan Miller, MD; and Yannek Leiderman, MD, PhD

11.03.22

AAO '22 Late-Breaking Talks: Biosimilar Phase 3 Data and TRUCKEE Update

Anat Loewenstein, MD; and Ramanath Bhandari, MD

10.25.22

AAO '22: GATHER2 Study Results

Arshad Khanani, MD, MS

10.13.22

New Retina Radio Journal Club: Latest Literature in Stickler Syndrome and GRTs

Yoshi Yonekawa, MD, PhD; Peter Campbell, MD; Karen Jeng-Miller, MD; and Prethy Rao, MD

09.30.22

New Retina Radio Journal Club: Updates in ROP

Yoshihiro Yonekawa, MD, PhD; Peter Campbell, MD; Karen Jeng-Miller, MD; and Prethy Rao, MD

09.15.22

ASRS Meeting Coverage Day 3: DR Biomarkers and Gene Tx for Achromatopsia

Jennifer Lim, MD; and Lejla Vajzovic, MD

08.25.22

New Retina Radio Journal Club: Multifocal, Indolent, Nonprogressive Choroidal Lesions

Kyle Kovacs, MD; Cynthia Qian, MD; and David Xu, MD

08.04.22

ASRS Meeting Coverage Day 2: Diabetic Eye Disease Updates

John Kitchens, MD; and Michael Allingham, MD, PhD

07.28.22

ASRS Meeting Coverage Day 1: TALON and TRUCKEE in Wet AMD

Carl Regillo, MD; and Carl Danzig, MD

07.14.22

New Retina Radio Journal Club: Recurrent RRD Management

Kyle Kovacs, MD; Cynthia Qian, MD; David Xu, MD

06.30.22

Luminaries in Retina: The Life and Career of Steve Charles, MD, FACS, FICS, FASRS

John W. Kitchens, MD; and Steve Charles, MD, FACS, FICS, FASRS

06.23.22

New Retina Radio Journal Club: Pentosan Polysulfate Maculopathy

Basil Williams, MD; Karen Jeng-Miller, MD, MPH; M. Ali Khan, MD; and Katherine Talcott, MD

06.09.22

ARVO Meeting Coverage Day 3: CANDELA and ARCHWAY Data

David Brown, MD and Robert Mittra, MD

06.02.22

ARVO Meeting Coverage Day 2: Pipeline Therapies in GA

Allen C. Ho, MD and Jared Nielsen, MD, MBA

05.26.22

ARVO Meeting Coverage Day 1: LIGHTSITE III and DERBY/OAKS at 18 Months

05.19.22

New Treatment Options and Considerations for AMD

Allen C. Ho, MD; Robyn Guymer AM, MBBS, PhD, FRANZCO, FAHMS; Charles C. Wykoff, MD, PhD; and Diana V. Do, MD

05.12.22

New Retina Radio Journal Club: Trends in Retina Reimbursement

Eric Nudleman, MD, PhD; John Miller, MD; Thanos Papakostas, MD; and Priya Vakharia, MD

04.21.22

New Retina Radio Journal Club: Diversity in Clinical Trials

Basil Williams, MD; Karen Jeng-Miller, MD, MPH; M. Ali Khan, MD; and Katherine Talcott, MD

03.31.22

New Retina Radio Journal Club: PPV vs PnR for RRD

Eric Nudleman, MD, PhD; John Miller, MD; Thanos Papakostas, MD; and Priya Vakharia, MD

03.24.22

Art of Drug Choice: Treating New Wet AMD Patients

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD, and Joseph M. Coney, MD

03.17.22

Art of Drug Choice: Who Is Best Suited for Extended-duration Therapy?

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD; and Joseph M. Coney, MD

03.03.22

Art of Drug Choice: The Latest Advances in Wet AMD Therapy

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD, and Joseph M. Coney, MD

02.24.22

Anti-VEGF, A Biography: Part 3

John D. Pitcher III, MD; Bob Avery, MD; David Brown, MD; Jeffrey Heier, MD; Nancy Holekamp, MD; Kirk Packo, MD; Phillip Rosenfeld, MD, PhD; and Bob Vitti, MD

02.17.22

Anti-VEGF, A Biography: Part 2

John D. Pitcher III, MD; Bob Avery, MD; Dave Brown, MD; Anne Fung, MD; Jeffrey Heier, MD; Andrew Moshfeghi, MD, MBA; Kirk Packo, MD; and Philip Rosenfeld, MD, PhD

02.11.22

Exploring the clinical development program for an innovative, continuous delivery treatment for nAMD

John Kitchens, MD and Dante Pieramici, MD

02.03.22

Tackling PVR in the OR

Allen C. Ho, MD; Robert L. Avery, MD; Dean Eliott, MD; Avni P. Finn, MD, MBA; Ajay Kuriyan, MD, MS; and M. Ali Khan, MD

01.27.22

Anti-VEGF, A Biography: Part 1

John D. Pitcher III, MD; Tony Adamis, MD; Bob Avery, MD; Jeff Heier, MD; and Kirk Packo, MD

01.18.22

Perspectives on an innovative drug delivery system for nAMD: From training to initial experiences

01.04.22

Matching Patients to Therapy in Wet AMD: Lifestyle Factors That Guide Treatment

John Kitchens, MD; Murtaza Adam, MD; and Aleksandra Rachitskaya, MD

12.22.21

Matching Patients to Therapy in Wet AMD: Deciding Who Is Best Suited for Long-Duration Treatments

John Kitchens, MD; Lisa Faia, MD; and Sumit Sharma, MD

12.17.21

AAO 2021: Updates in Uveitis and Trauma

Glenn Jaffe, MD; and Nicole Koulisis, MD

12.14.21

Matching Patients to Therapy in Wet AMD: How New Technology May Alleviate Treatment Burden

John Kitchens, MD; Carl Regillo, MD; and Adrienne Scott, MD

12.10.21

New Retina Radio Journal Club: Medical Management of Macular Holes

Christina Weng, MD, MBA; Brian Do, MD; Mrinali Gupta, MD; and Dmitra Skondra, MD, PhD,

12.07.21

The Latest on Gene Therapy for Inherited Retinal Diseases

12.03.21

PALADIN for DME and ROP Updates From the ICROP

Michael Singer, MD; and R.V. Paul Chan, MD, MSc, MBA

11.30.21

AAO 2021 Late Breakers: DAVIO and NORSE-2

David Boyer, MD; and Firas Rahhal, MD

11.26.21

New Retina Radio Journal Club: Biosimilars in Wet AMD

Aleksandra Rachitskaya, MD; Emmanuel Chang, MD, PhD; Michael Klufas, MD; and Dmitra Skondra, MD

11.23.21

AAO 2021: Protocol W and Monitoring for Wet AMD

Raj Maturi, MD; and Usha Chakravarthy, MD

11.19.21

AAO 2021 Late Breakers: GATHER1 and ALTISSIMO

David Lally, MD; and Veeral Sheth, MD

11.16.21

Developing an innovative drug delivery system for nAMD

11.12.21

International Perspectives on ROP

Prof. Andreas Stahl, Dr. Maria Ana Martinez-Castellanos, Silke Mader

11.09.21

Luminaries in Retina: Kirk Packo, MD, FACS (Part 2)

John W. Kitchens, MD; Kirk Packo, MD, FACS

11.09.21

Luminaries in Retina: Kirk Packo, MD, FACS (Part 1)

John W. Kitchens, MD; Kirk Packo, MD, FACS

11.05.21

ASRS 2021 Coverage: The Pipeline for Wet AMD and GA

Mark Barakat, MD; and Nancy Holekamp, MD

10.29.21

ASRS 2021 Coverage: Losing GA Patients to Follow-up and DME Meta-analysis

Durga Borkar, MD; and M. Ali Khan, MD

10.22.21

ASRS 2021 Coverage: ARCHWAY and TENAYA/LUCERNE

Chirag Jhaveri, MD; and Karl Csaky, MD

10.19.21

Vitreous Opacities: How ODs and MDs Can Collaborate

John Kitchens, MD; Tarek Hassan, MD; and Walt Whitley, OD, MBA

10.15.21

New Retina Radio Journal Club: Treating CMV with Adoptive Immunotherapy

Christina Weng, MD, MBA; Mrinali Gupta, MD; Brian Do, MD; and Dimitra Skondra, MD, PhD

10.08.21

International Perspectives: RVO

Jennifer Arnold, MD; Ramin Tadayoni, MD; and Armin Wolf, MD

10.01.21

Vitreous Opacities: Hearing from Anterior and Posterior Segment Surgeons

John Kitchens, MD; María Berrocal, MD; and Elizabeth Yeu, MD

09.17.21

New Retina Radio Journal Club: Exudative AMD in FILLY and GATHER1 Results

Aleksandra Rachitskaya, MD; Emmanuel Chang, MD, PhD; Michael Klufas, MD; and Dmitra Skondra, MD

09.10.21

The Art of Drug Choice: International Panel in Wet AMD: Safety Data

Arshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC

09.03.21

Vitreous Opacities: Innovations and the Decision to Operate

John Kitchens, MD; S.K. Steven Houston III, MD; Christina Weng, MD, MBA

09.01.21

The Art of Drug Choice: International Panel in Wet AMD: The Pipeline

Arshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC

08.27.21

International Perspectives: DME

Patricio Schlottmann; Catherine Creuzot-Garcher; and Adnan Tufail

08.20.21

The Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to Watch

Arshad Khanani, MD, MA; Justus Garweg, MD; Seenu Hariprasad, MD; Peter Kertes, MD, FRCSC

08.13.21

New Retina Radio Journal Club: Data in the Wake of COVID-19

Caroline Baumal, MD; M. Ali Khan, MD; Vlad Matei, MD; Christina Weng, MD, MBA

08.06.21

The Art of Drug Choice: International Panel in Wet AMD: When and Why Switching Therapy Makes Sense

Arshad M. Khanani, MD, MA; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; and Peter Kertes, MD, FRCSC

07.29.21

Surgical options for treating AMD: Clinical Implications and Impact

Carl D. Regillo, MD; Carl Awh, MD; and Dante Pieramici, MD

07.26.21

Advances in Gene Therapy for Wet AMD

Allen C. Ho, MD; Robert L. Avery, MD; Peter Campochiaro, MD, PhD; Jeffrey S. Heier, MD; Szilárd Kiss, MD; and Charles Wykoff, MD, PhD

07.16.21

New Retina Radio Journal Club: Masking in Retina: Keeping Patients Safe from Bacterial Exposure

Yoshihiro Yonekawa, MD; Jonathan Chang, MD; Ajay Kuriyan, MD; and Paula Pecen, MD

07.09.21

Reconsidering treatment endpoints in real-world clinical practice: is achieving a favorable retreatment interval a goal of therapy?

Carl D. Regillo, MD; Jennifer Lim, MD; and Charles Wykoff, MD, PhD

06.25.21

New Retina Radio Journal Club: Autologous Retina Transplant for Macular Holes

Caroline Baumal, MD; M. Ali Khan, MD; Vlad Matei, MD; and Christina Weng, MD, MBA

06.11.21

Real-world impact of patients lost to follow-up: factors that drive nonadherence and strategies for encouraging better follow-up from patients

Carl D. Regillo, MD; Margaret Chang, MD; and David Eichenbaum, MD

06.04.21

ARVO 2021 Coverage: NGM621 and COOG2

David Eichenbaum, MD; and Amy Schefler, MD

05.28.21

ARVO 2021: GATHER1 Study and CME After RRD Surgery

Veeral Sheth, MD; and Matthew Starr, MD

05.21.21

ARVO 2021 Coverage: TENAYA/LUCERNE Results—and Is Fluid OK in Wet AMD?

Arshad Khanani, MD, MA; and David Lally, MD

05.14.21

New Retina Radio Journal Club: Protocol W: How Might the Data Change Practice?

Yoshihiro Yonekawa, MD; Ajay Kuriyan, MD; Anton Orlin, MD; and Paula Pecen, MD

04.15.21

New Retina Radio Journal Club: PRO Study Group Papers: Part 2

Jay Sridhar, MD; Brian Do, MD; Sabin Dang, MD; and Avni Finn, MD, MBA

03.30.21

New Retina Radio Journal Club: PRO Study Group Papers: Part 1

Jay Sridhar, MD; Brian Do, MD; Sabin Dang, MD; and Avni Finn, MD, MBA

03.12.21

Angiogenesis 2021: Wet AMD

John Kitchens, MD; Diana Do, MD; and Carl Regillo, MD

03.08.21

New Retina Radio Journal Club: OCT Biomarkers in New Onset GA

Yoshihiro Yonekawa, MD; Marion Munk, MD, PhD; Lejla Vajzovic, MD; and David Xu, MD

03.04.21

Angiogenesis 2021: Geographic Atrophy

John Kitchens, MD; Pravin Dugel, MD, and SriniVas Sadda, MD

03.01.21

Let’s Talk Diversity and Inclusion

02.25.21

New Retina Radio Journal Club: Anti-VEGF vs Surgery + PRP for VH with PDR

Aleksandra Rachitskaya, MD; Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD

02.10.21

New Retina Radio Journal Club: Phase 2 LADDER Study Data

Aleksandra Rachitskaya, MD; Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD

02.08.21

International Perspectives: Digital Solutions for the Management of Amblyopia

Prof. Richard Harrad; Prof. Ben Thompson; and Prof. Ann Webber

01.28.21

International Perspectives: How Will Artificial Intelligence Affect the Practice of Ophthalmology?

Dr Peter Kaiser; Prof. James Wolffsohn; and Dr Pearce Keane

01.25.21

Clinical Impacts From AAO 2020: Drs. Singh, Ehlers, and Gillies

Rishi Singh, MD; Justis Ehlers, MD; and Mark Gillies, MD, PhD

01.20.21

International Perspectives: Fluid in Neovascular Age-Related Macular Degeneration – Evolution of Understanding

Rishi Singh; Jennifer Arnold; Mark Gillies; and SriniVas Sadda

01.08.21

New Retina Radio Journal Club: Imaging Modalities in DR

Jorge Fortun, MD; Cynthia Qian, MD; Christina Weng, MD, MBA; and Basil Williams, MD

12.21.20

New Retina Radio Journal Club: Intravitreal Dexamethasone Implant in DME Patients

Jorge Fortun, MD; Cynthia Qian, MD; Christina Weng, MD, MBA; and Basil Williams, MD

12.17.20

Clinical Impacts From AAO 2020: Drs. Singh, Do, and Heier

Rishi Singh, MD; Diana Do, MD; and Jeffrey Heier, MD

12.07.20

DRCR Retina Network Protocol AB at AAO

Andrew Antoszyk, MD

12.02.20

AAO Late Breaker: IRIS Registry Data on GA

Ehsan Rahimy, MD

11.30.20

Coding Changes for 2021 at AAO

Joy Woodke

11.25.20

AAO Late Breaker: Ang-2 Mediation in DME Therapy

Karl Csaky, MD, PhD

11.23.20

Retinal Arteriolar Macroaneurysm and Anti-VEGF Therapy at AAO

J. Fernando Arevalo, MD, PhD

11.20.20

AAO Late Breaker: KSI-301 in DME Therapy

Arshad M. Khanani, MD, MA

11.19.20

The Art of Drug Choice: Wet AMD and the Latest Data

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

11.19.20

The Art of Drug Choice: Phase 3 Trials in Wet AMD

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

11.19.20

The Art of Drug Choice: Wet AMD Pipeline

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

11.19.20

The Art of Drug Choice: Safety in Wet AMD

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

11.18.20

ARCHWAY at AAO

Nancy Holekamp, MD

11.10.20

New Retina Radio Journal Club: Putting the Fun Back in Journal Club

John Kitchens, MD; Jorge Fortun, MD; Cynthia Qian, MD; Christina Weng, MD, MBA; and Basil Williams, MD

10.30.20

International Perspectives: Clinical considerations for optimal management of patients with IRDs

Prof. Bart Leroy; Prof. Isabelle Audo; and Prof. Robert Maclaren

10.16.20

Back to Practice: Combating Patient Misinformation Regarding COVID-19

John W. Kitchens, MD; Patricio Schlottmann, MD; Nicole Eter, MD; and Adnan Tufail, MBBS, MD, FRCOphth

10.15.20

Back to Practice: Telemedicine & Combating Patient Misinformation

John Kitchens, MD; Judy E. Kim, MD; Byron Ladd, MD; and Carl D. Regillo, MD

10.03.20

Back to Practice: Telemedicine in the COVID-19 Era

John W. Kitchens, MD; Francesco Boscia, MD; David Steel, MBBS, FRCOphth; and Ramin Tadayoni, MD, PhD

10.01.20

Back to Practice: Academic Settings in a Pandemic: Rules and Regulations

John Kitchens, MD; Dilraj Grewal, MD; Adrienne Scott, MD; and Elliott Sohn, MD

09.16.20

Back to Practice: Educating the Next Generation of Surgeons During COVID-19

John Kitchens, MD; Sophie Bakri, MD; Julia Haller, MD; and R.V. Paul Chan, MD, MSc, MBA

08.31.20

jCell Therapy for Retinitis Pigmentosa and Phase 2B Data

Anthony Joseph, MD

08.28.20

Back to Practice: What Happens During a COVID-19 Resurgence?

John W. Kitchens, MD; Steve Charles, MD; Amy Schefler, MD; and Jayanth Sridhar, MD

08.26.20

Back to Practice: Technology and COVID-19: Necessity Is the Mother of Invention

John W. Kitchens, MD; María H. Berrocal, MD; Jean-Francois Korobelnik, MD, PhD; and Manish Nagpal, MBBS, MS, FRCS

08.21.20

Treat-and-Extend in the Real World

Michael Singer, MD

08.12.20

Opioid Prescribing Patterns Among Retina Specialists

Yoshi Yonekawa, MD

08.04.20

Continuous Dosing in LADDER

Dilsher Dhoot, MD

08.03.20

Back to Practice: COVID-19 Clinical and Surgical Protocols: Which Changes Are Here to Stay?

John W. Kitchens, MD; Marí a Ana Castellanos-Martinez, MD; and Matteo Forlini, MD

07.30.20

Back to Practice: Education as In-Person Meetings Are Paused

John W. Kitchens, MD; Anat Loewenstein, MD; and Timothy G. Murray, MD, MBA

06.30.20

Faricimab in Phase 2 and 3

Carl Danzig, MD

08.28.17

Beyond the Walls of ORs and Borders of Nations

Don D'Amico, MD, R.V. Paul Chan, MD, and Pravin Dugel, MD

06.14.17

Retina Is for the Birds

James C. Major Jr, MD, PhD

02.24.17

Alphabet Soup: PhD, MBA, JD, MS

Derek Kunimoto, MD, JD; Paul Hahn, MD, PhD; David Almeida, MD, PhD, MBA; and Scott Walter, MD, MS.

01.23.17

The Dating Game

Geeta Lalwani, MD, and Charlie Mango, MD

12.28.16

Je Ne Sais Quoi

Julia Haller, MD; Anat Loewenstein, MD; Geeta Lalwani, MD; Jessica Randolph, MD; and Talisa de Carlo, MD

11.16.16

Ophthalmologist Barbie

Julia Haller, MD; Anat Loewenstein, MD; Jessica Randolph, MD; and Talisa de Carlo, MD

New Retina Radio Journal Club w/ VBS: Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab

MORE EPISODES